Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: A novel gene related to nuclear envelopathies
Copyright policy )Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: A novel gene related to nuclear envelopathies
We performed genome-wide homozygosity mapping and mapped a novel myopathic phenotype to chromosomal region 1q25 in a consanguineous family with three affected individuals manifesting proximal and distal weakness and atrophy, rigid spine and contractures of the proximal and distal interphalangeal hand joints. Additionally, cardiomyopathy and respiratory involvement were noted. DNA sequencing of torsinA-interacting protein 1 (TOR1AIP1) gene encoding lamina-associated polypeptide 1B (LAP1B), showed a homozygous c.186delG mutation that causes a frameshift resulting in a premature stop codon (p.E62fsTer25). We observed that expression of LAP1B was absent in the patient skeletal muscle fibres. Ultrastructural examination showed intact sarcomeric organization but alterations of the nuclear envelope including nuclear fragmentation, chromatin bleb formation and naked chromatin. LAP1B is a type-2 integral membrane protein localized in the inner nuclear membrane that binds to both A- and B-type lamins, and is involved in the regulation of torsinA ATPase. Interestingly, luminal domain-like LAP1 (LULL1)-an endoplasmic reticulum-localized partner of torsinA-was overexpressed in the patient's muscle in the absence of LAP1B. Therefore, the findings suggest that LAP1 and LULL1 might have a compensatory effect on each other. This study expands the spectrum of genes associated with nuclear envelopathies and highlights the critical function for LAP1B in striated muscle.
- Bilkent University Turkey
- Hacettepe University Turkey
- Istanbul University Turkey
Male, family, genetic association, sequence analysis, Myopathy, DNA Mutational Analysis, Fluorescent Antibody Technique, cell nucleus membrane, LAP1B protein, human, nuclear protein, molecular pathology, genetics, Frameshift Mutation, nuclear envelopathy, adult, protein function, Pedigree, TOR1AIP1, priority journal, muscle disease, histopathology, muscle biopsy, LAP1B protein, phenotype, Nuclear Envelope, Molecular Sequence Data, Microscopy, Electron, Transmission, transmission electron microscopy, case report, stop codon, Humans, Family, human, RNA, Messenger, Amino Acid Sequence, skeletal muscle, lamin B, protein expression, lamin A, gene location, binding site, echography, gene mapping, molecular dynamics, torsin A interacting protein 1 gene, amino acid sequence, carrier protein, Cytoskeletal Proteins, gene function, TOR1AIP2 protein, molecular genetics, Carrier Proteins, disease activity, frameshift mutation, Muscle Fibers, Skeletal, fluorescent antibody technique, protein binding, Muscular Dystrophies, binding affinity, membrane protein, gene mutation, messenger RNA, article, pedigree, Nuclear Proteins, lamina associated polypeptide 1B, ultrastructure, unclassified drug, female, Female, muscular dystrophy, Sarcomeres, Adult, Adolescent, protein localization, TOR1AIP2 protein, human, promoter region, male, controlled study, gene, gene identification, disease association, Membrane Proteins, nucleotide sequence, LAP1, Muscular dystrophy, human tissue, clinical feature, adolescent, pathology, sarcomere, protein determination, metabolism
Male, family, genetic association, sequence analysis, Myopathy, DNA Mutational Analysis, Fluorescent Antibody Technique, cell nucleus membrane, LAP1B protein, human, nuclear protein, molecular pathology, genetics, Frameshift Mutation, nuclear envelopathy, adult, protein function, Pedigree, TOR1AIP1, priority journal, muscle disease, histopathology, muscle biopsy, LAP1B protein, phenotype, Nuclear Envelope, Molecular Sequence Data, Microscopy, Electron, Transmission, transmission electron microscopy, case report, stop codon, Humans, Family, human, RNA, Messenger, Amino Acid Sequence, skeletal muscle, lamin B, protein expression, lamin A, gene location, binding site, echography, gene mapping, molecular dynamics, torsin A interacting protein 1 gene, amino acid sequence, carrier protein, Cytoskeletal Proteins, gene function, TOR1AIP2 protein, molecular genetics, Carrier Proteins, disease activity, frameshift mutation, Muscle Fibers, Skeletal, fluorescent antibody technique, protein binding, Muscular Dystrophies, binding affinity, membrane protein, gene mutation, messenger RNA, article, pedigree, Nuclear Proteins, lamina associated polypeptide 1B, ultrastructure, unclassified drug, female, Female, muscular dystrophy, Sarcomeres, Adult, Adolescent, protein localization, TOR1AIP2 protein, human, promoter region, male, controlled study, gene, gene identification, disease association, Membrane Proteins, nucleotide sequence, LAP1, Muscular dystrophy, human tissue, clinical feature, adolescent, pathology, sarcomere, protein determination, metabolism
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).75 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!